The EGFR pathway is a widely recognized oncogenic pathway for non-small cell lung cancer (NSCLC), which represents approximately 75% of lung cancers (Bethune et al., 2010; Hsu et al., 2019). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.